SUBSCRIBE
SUBSCRIBE
News   Drug Development

FDA (JOBS) Lifts Clinical Hold on Adolor Corporation Bowel Drug

July 3, 2008 | 
1 min read
EXTON, Pa. - Adolor Corp. said Thursday the Food and Drug Administration has lifted its clinical hold on the company's Entereg drug in chronically constipated patients taking opioid pain drugs.
Clinical research Phase 3 Regulatory
MORE ON THIS TOPIC
Light at the end of railroad tunnel. Natural lighting.
FDA
UniQure snags May Day decision date for Huntington’s gene therapy after arduous year
November 2, 2026
 · 
2 min read
 · 
Heather McKenzie
Wind up Earth globe green-blue pastel color on pink background. Designed in minimal concept. 3D Render.
Drug Development
Can Saudi Arabia’s burgeoning biotech hub withstand geopolitical pressures?
November 2, 2026
 · 
6 min read
 · 
Jennifer C. Smith-Parker
misty canyon with sharp cliff and lonely tree iin Delika
Neurodegeneration
Acumen scraps sole asset after Alzheimer’s fail, plunging stock 80%
October 30, 2026
 · 
2 min read
 · 
Gabrielle Masson
Pictured: Illustration of cancer cells being held in the crosshairs of a scope
Opinion
Once undruggable, the Wnt/B-catenin pathway shows increasing promise
October 30, 2026
 · 
5 min read
 · 
Rahul Aras